Add to Favorites Newsroom RSS Share
Boston, MA USA

Our News on Newswise


David A. Solá-Del Valle, M.D., Joins Mass. Eye and Ear Glaucoma Service

David A. Solá-Del Valle, M.D., a board-certified ophthalmologist and fellowship-trained glaucoma specialist, has recently joined the Glaucoma Service at Mass. Eye and Ear.
20-Feb-2018 3:05 PM EST Add to Favorites


Janey L. Wiggs, M.D., Ph.D., FARVO, Receives ARVO Dr. David L. Epstein Award

Janey L. Wiggs, M.D., Ph.D., FARVO, Associate Chief of Ophthalmology Clinical Research and Associate Director of the Howe Laboratory at Massachusetts Eye and Ear, is the 2018 recipient of the Dr. David L. Epstein Award
20-Feb-2018 2:05 PM EST Add to Favorites


CRISPR Therapy Preserves Hearing in Progressive Deafness Model

Hearing loss is the most common form of sensory loss in humans, and almost half of cases have an underlying genetic cause.
20-Dec-2017 11:05 AM EST Add to Favorites


Invasive Cells in Head and Neck Tumors Predict Cancer Spread

Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition — which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment — are more likely to...
21-Nov-2017 9:45 AM EST Add to Favorites


Brain Training Can Improve Our Understanding of Speech in Noisy Places

For many people with hearing challenges, trying to follow a conversation in a crowded restaurant or other noisy venue is a major struggle, even with hearing aids. Now, Mass. Eye and Ear researchers reporting in Current Biology on October 19th have...
13-Oct-2017 12:05 PM EDT Add to Favorites

Researchers Identify Potential Biomarkers of Age-Related Macular Degeneration

Patients with any stage of age-related macular degeneration (AMD) carry signs of the disease in their blood that may be found through special laboratory tests, according to a new study led by AMD researchers based at Massachusetts Eye and Ear.
8-Sep-2017 12:05 PM EDT Add to Favorites


Researchers Identify Key Compounds to Resolve Abnormal Vascular Growth in Age-Related Macular Degeneration

A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical model, according to a new study led by Massachusetts Eye and Ear researchers.
18-Aug-2017 2:00 PM EDT Add to Favorites

Genome Editing with CRISPR-Cas9 Prevents Angiogenesis of the Retina

A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing techniques with...
24-Jul-2017 5:05 PM EDT Add to Favorites

see all news

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Chat now!